← SynDRA
NEMIRALISIB
SynDRA canonical compound SYN0034403 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PIK3CD |
|---|
All known targets
- PIK3CD
- KCNH2
- PIK3CA
- PIK3CB
- PIK3CG
Mechanisms of action (all sources)
- PIK3CD INHIBITOR
- PI3-kinase p110-delta subunit inhibitor
- KCNH2 INHIBITOR
- PIK3CA INHIBITOR
- PIK3CB INHIBITOR
- PIK3CG INHIBITOR
Drug classes
- Protein Kinase Inhibitors
Cross-references
Synonyms
- GSK-2269557 FREE BASE
- GSK-2269557A
- GSK2269557A
- GSK-2269557 free base
- OEP8JJ3OZR
- nemiralisibum
- RefChem:927577
- Nemiralisib [USAN]
- PI3Kdelta inhibitor GS2269557
- MFCD28128611
- UNII-OEP8JJ3OZR
- NEMIRALISIB [INN]
- Nemiralisib (USAN/INN)
- GSK2269557 free base
- NEMIRALISIB [WHO-DD]
- SCHEMBL109919
- GTPL9425
- orb1707242
- Nemiralisib (GSK2269557)
- GSK2269557 (free base)
- SCHEMBL29356978
- SCHEMBL29493085
- C26H28N6O
- MCIDWGZGWVSZMK-UHFFFAOYSA-N
- GLXC-20013
- EAC03671
- EX-A5754
- BDBM50004529
- HY-19535A
- s7937
- AKOS027422840
- CCG-269127
- compound 2 [PMID: 26301626]
- CS-5683
- AC-35584
- DA-36928
- MS-27918
- D11267
- VVX
Look up NEMIRALISIB in the interactive SynDRA portal →